These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 16550883)
41. [Diabetes mellitus--high costs, good prospects]. Heinzl S Med Monatsschr Pharm; 2006 Mar; 29(3):83. PubMed ID: 16550879 [No Abstract] [Full Text] [Related]
42. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)]. Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091 [TBL] [Abstract][Full Text] [Related]
43. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus. Cobden D; Lee WC; Balu S; Joshi AV; Pashos CL Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200 [TBL] [Abstract][Full Text] [Related]
44. Inhaled insulin--does it become reality? Siekmeier R; Scheuch G J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634 [TBL] [Abstract][Full Text] [Related]
45. Nanoparticle strategies for the oral delivery of insulin. Damgé C; Reis CP; Maincent P Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928 [TBL] [Abstract][Full Text] [Related]
46. Insulin management: a guide for the home health nurse. Beacham T; Williams PR; Askew R; Walker J; Schenk L; May M Home Healthc Nurse; 2008; 26(7):421-8; quiz 429-30. PubMed ID: 18622219 [TBL] [Abstract][Full Text] [Related]
47. [Gene engineered insulin and its pharmaceutical analogs]. Gusarov DA; Gusarova VD; Bairamishvili DI; Mironov AF Biomed Khim; 2008; 54(6):624-42. PubMed ID: 19205422 [TBL] [Abstract][Full Text] [Related]
48. [A new aspect in diabetes treatment. Results of an orally administered insulin mimetic]. Winckler T Pharm Unserer Zeit; 2001; 30(2):131-4. PubMed ID: 11279983 [No Abstract] [Full Text] [Related]
49. Lantus: a new insulin. Keresztes PA; Brick K Medsurg Nurs; 2003 Dec; 12(6):408-10. PubMed ID: 14725154 [No Abstract] [Full Text] [Related]
50. Insuline glusine (Apidra): a new rapid-acting insulin. Med Lett Drugs Ther; 2006 Apr; 48(1233):33-4. PubMed ID: 16625142 [TBL] [Abstract][Full Text] [Related]
51. [Selection and dosing of insulin preparations]. Kajinuma H Nihon Rinsho; 1997 Nov; 55 Suppl():238-42. PubMed ID: 9434474 [No Abstract] [Full Text] [Related]
52. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting. Hahr AJ; Molitch ME Am J Ther; 2008; 15(6):543-50. PubMed ID: 19127139 [TBL] [Abstract][Full Text] [Related]